Guselkumab, sold under the brand name Tremfya, is a monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis, psoriatic arthritis, and ulcerative colitis. From Wikipedia
Despite strong earnings and sales, J&J's stock falls below its 200-day moving average.